Answers are grounded in this paper and cite their sources.
Clinical case demonstrates improved diabetes management in a female with MODY 8 due to CEL mutation, indicating the importance of genetic testing.
Introduction Maturity-Onset diabetes of the Young (MODY) is a monogenic form of diabetes often mimicking Type 1 or Type 2 diabetes MODY type 8 (MODY 8), resulting from mutations in the CEL gene, is rare and associated with pancreatic exocrine dysfunction and hepatic abnormalities. Clinical Case A 41-year-old female, BMI 26.1 kg/m², diagnosed with diabetes at age 16, had persistent hyperglycemia despite insulin therapy. Her phenotype was atypical for Type 1 or 2 diabetes, exhibiting adequate C-peptide levels, negative autoimmune markers, hyperlipidemia, hepatic steatosis, elevated transaminases, and vitamin D deficiency. Genetic testing identified a CEL mutation (c.1843del, p. Ala615Profs92), heterozygous and likely pathogenic. An incidental WFS1 mutation (c.2600G>A, p. Trp867) was also found. Identification of the CEL mutation prompted a shift from insulin to Tirzepatide, Metformin, and SGLT2 inhibitors. Follow-up showed improvement in HbA1c to 7.6% and BMI to 22.94 kg/m². Conclusion Clinicians should consider MODY in non-obese, early-onset diabetic patients lacking autoimmune markers. Genetic testing facilitates precision diagnosis, personalized therapy, and reduces unnecessary insulin use.
No takes yet. Share an insight, caveat, or question.
Nasir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: